Business
Why the Mesoblast (ASX:MSB) share price crashed 45% lower today
The Mesoblast limited (ASX: MSB) share price has returned from its trading halt and crashed significantly lower.
In early trade the biotechnology company’s shares are down a massive 45% to $2.08.
Why is the Mesoblast share price crashing lower?
Investors have been selling the company’s shares this morning after it provided an update on the randomised controlled trial of its remestemcel-L product in ventilator-dependent patients with moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection.
According to the release, the Data Safety Monitoring Board (DSMB) has performed a third interim analysis on the trial’s first 180 patients.
The trial was aiming to achieve a primary endpoint of 43% reduction…
-
Business17 hours agoHow to choose your first ASX ETF
-
Business20 hours agoAged 30 and earning an average wage? You’re now set up for retirement. Here’s how
-
Business16 hours agoHow to earn $100 a month of passive income from ASX dividends
-
Noosa News16 hours agoGelato Messina and Tony’s Chocolonely Have Collabed on a Super Gooey Bake-At-Home Cookie Pie Perfect for Cold Winter Nights